TRANSMIT ENT (01326) announced that the company is still in the process of collecting and organizing required materials and documents from Wenlan to meet the needs for preparing consolidated financial statements and supporting auditor procedures. As a result, the company requires additional time to compile its 2024/2025 annual results.
Consequently, the publication of the 2024/2025 annual results and the dispatch of the 2024/2025 annual report will be delayed. The company has requested that trading in its shares be suspended on the Stock Exchange starting from 9:00 AM on Thursday, October 2, 2025, pending the publication of the 2024/2025 annual results announcement.